Daily Vaginal Application of Dienogest (Visanne©) for 3 Months in Symptomatic Deeply Infiltrating Rectovaginal Endometriosis: A Possible New Treatment Approach?

about

Daily Vaginal Application of Dienogest (Visanne©) for 3 Months in Symptomatic Deeply Infiltrating Rectovaginal Endometriosis: A Possible New Treatment Approach?

Item

http://www.wikidata.org/entity/Q55002806

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Daily Vaginal Application of D ...... ssible New Treatment Approach?

@en

Daily Vaginal Application of Dienogest

@nl

type

Item

label

Daily Vaginal Application of D ...... ssible New Treatment Approach?

@en

Daily Vaginal Application of Dienogest

@nl

prefLabel

Daily Vaginal Application of D ...... ssible New Treatment Approach?

@en

Daily Vaginal Application of Dienogest

@nl

P1476

Daily Vaginal Application of D ...... ssible New Treatment Approach?

@en

P2093

Andreas D Ebert

http://www.w3.org/2001/XMLSchema#string

P2860

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial

The diagnosis and treatment of deep infiltrating endometriosis.

National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis: Long Version - AWMF Registry No. 015-045

Dienogest in the treatment of endometriosis: systematic review.

"Per vaginam" topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review.

Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience.

Consensus on Recording Deep Endometriosis Surgery: the CORDES statement.

Surgery versus hormonal therapy for deep endometriosis: is it a choice of the physician?

Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission.

Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.

P304

8175870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2018/8175870

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Andreas D Ebert

P577

2018-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29862105

http://www.w3.org/2001/XMLSchema#string

P921

endometriosis

P932

5971254

http://www.w3.org/2001/XMLSchema#string